- Home
- BCTX vs WKSP Comparison
BCTX vs WKSP Comparison
Compare BCTX & WKSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCTX
- WKSP
- Stock Information
- Founded
- BCTX 2014
- WKSP 2003
- Country
- BCTX Canada
- WKSP United States
- Employees
- BCTX N/A
- WKSP N/A
- Industry
- BCTX Biotechnology: Pharmaceutical Preparations
- WKSP Auto Parts:O.E.M.
- Sector
- BCTX Health Care
- WKSP Consumer Discretionary
- Exchange
- BCTX Nasdaq
- WKSP Nasdaq
- Market Cap
- BCTX 14.4M
- WKSP 14.6M
- IPO Year
- BCTX N/A
- WKSP N/A
- Fundamental
- Price
- BCTX $7.72
- WKSP $3.47
- Analyst Decision
- BCTX Strong Buy
- WKSP Strong Buy
- Analyst Count
- BCTX 1
- WKSP 3
- Target Price
- BCTX $40.00
- WKSP $12.83
- AVG Volume (30 Days)
- BCTX 92.9K
- WKSP 536.3K
- Earning Date
- BCTX 10-28-2025
- WKSP 08-13-2025
- Dividend Yield
- BCTX N/A
- WKSP N/A
- EPS Growth
- BCTX N/A
- WKSP N/A
- EPS
- BCTX N/A
- WKSP N/A
- Revenue
- BCTX N/A
- WKSP $12,395,166.00
- Revenue This Year
- BCTX N/A
- WKSP $163.94
- Revenue Next Year
- BCTX N/A
- WKSP $78.39
- P/E Ratio
- BCTX N/A
- WKSP N/A
- Revenue Growth
- BCTX N/A
- WKSP 232.13
- 52 Week Low
- BCTX $6.00
- WKSP $2.44
- 52 Week High
- BCTX $294.00
- WKSP $12.00
- Technical
- Relative Strength Index (RSI)
- BCTX 40.75
- WKSP 53.39
- Support Level
- BCTX $7.28
- WKSP $3.01
- Resistance Level
- BCTX $8.82
- WKSP $4.30
- Average True Range (ATR)
- BCTX 0.74
- WKSP 0.33
- MACD
- BCTX 0.58
- WKSP 0.06
- Stochastic Oscillator
- BCTX 60.82
- WKSP 45.61
About BCTX BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp is a clinical-stage immuno-oncology company. The group is developing an entirely new class of targeted immunotherapies to transform cancer care. Its product candidate Bria-IMT, is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC is breast cancer that has spread to other tissues). Bria-IMT is a targeted cell-based immunotherapy. The company is engaged in developing a Bria-OTS platform of personalized off-the-shelf cell-based immunotherapies. It is being evaluated in a Phase 1/2 clinical study and the treatment is initially focused on patients with breast cancer with an extension to prostate cancer, and other cancers.
About WKSP Worksport Ltd.
Worksport Ltd through its subsidiaries, designs, develops, manufactures, and owns the IP on a variety of tonneau covers, solar integrations, and NP (Non-Parasitic), Hydrogen-based true green energy solutions for the sustainable, clean energy, and automotive industries. The company's product includes soft vinyl tonneau covers and hard aluminum tonneau covers. It operates in two reporting segments for financial reporting purposes: Hard Tonneau Covers and Soft Tonneau Covers. Geographically, the company operates in Canada, United States and Other Countries.